TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Daily Photo Galleries

Business Photo Galleries

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. Small retailers at intersection of social networks, foot traffic
  2. Iron ore price decline hurts U.S. Steel’s cost advantage over rivals
  3. 153-year-old Venango well pumps out oil, history
  4. Woman on dating site looks too good to be true: How to vet that pic
  5. Highmark and UPMC feud over canceled physician contracts
  6. Small businesses’ dilemma: Keep costly health care coverage or lose talented workers
  7. In ‘StockCity,’ real investing like game
  8. Test-tube tuna may be sea change
  9. Slow hunting, golf sales again drag down Dick’s profit
  10. Health care, gas drilling industries await Gov.-elect Wolf’s footprint
  11. Business Council for Peace program works to export profits, peace
Subscribe today! Click here for our subscription offers.